Timothy J. Bradley

Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

Ronald V. Lacro, Harry C. Dietz, Lynn A. Sleeper et al. · New England Journal of Medicine · 2014 · 522 citations · Full text

Medicine, Cardiology, Pharmacotherapy +9

Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades☆

Edward Hickey, Gruschen Veldtman, Timothy J. Bradley et al. · European Journal of Cardio-Thoracic Surgery · 2008 · 282 citations

Medicine, Cardiology, Surgery +15

De novo <i>ACTA2</i> mutation causes a novel syndrome of multisystemic smooth muscle dysfunction

Dianna M. Milewicz, John R. Østergaard, Leena Ala‐Kokko et al. · American Journal of Medical Genetics Part A · 2010 · 269 citations

Life Sciences, Cell Biology, Molecular Genetics +13

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Ronald V. Lacro, Harry C. Dietz, Lisa Wruck et al. · American Heart Journal · 2007 · 231 citations · Full text

Medicine, Cardiology, Pharmacology +16

Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging Measurements of Functional Single Ventricular Volumes, Mass, and Ejection Fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)††A list of participating institutions and investigators appears in the Appendix.

Renée Margossian, Marcy L. Schwartz, Ashwin Prakash et al. · The American Journal of Cardiology · 2009 · 224 citations

Medicine, Cardiology, Pediatrics +17